Design of Hollow Hyaluronic Acid Cylinders for Sustained Intravitreal Protein Delivery

作者: Erik Van Kampen , Craig Vandervelden , Amir Fakhari , Jian Qian , Cory Berkland

DOI: 10.1016/J.XPHS.2018.04.024

关键词: Protein solutionSelf-healing hydrogelsMaterials scienceSwellingHyaluronic acidHollow cylinderBiomedical engineeringMolding (process)DiffusionCylinder (engine)Pharmaceutical Science

摘要: A hollow cylinder intravitreal implant was developed to achieve sustained release of protein the retina for treatment retinal diseases. Hollow cylinders were fabricated by molding and cross-linking hyaluronic acid, major component vitreous humor. filled with a concentrated solution, properties walls tested. Cross-linked acid hydrogels swelling degrees as low 2.7 achieved means extend protein. capable releasing an antigen-binding fragment over 4 months at maximum rate μg per day. Protein from modeled using COMSOL Multiphysics® software, diffusion coefficients between 1.0 × 10-11 3.0 cm2/s yielded therapeutically effective levels Cylinders 1 mm outer radius loading >1 mg while least 2.5 day 4.5 months. Although smaller facilitate placement, decreasing severely limited drug loading. Design implants must balance high reduce device size control coefficient sustain release.

参考文章(54)
Paul J. Flory, Principles of polymer chemistry ,(1953)
Stefan Bagby, Kit I. Tong, Mitsuhiko Ikura, Optimization of protein solubility and stability for protein nuclear magnetic resonance Methods in Enzymology. ,vol. 339, pp. 20- 41 ,(2001) , 10.1016/S0076-6879(01)39307-2
Susanne Kirchhof, Manuel Gregoritza, Viktoria Messmann, Nadine Hammer, Achim M. Goepferich, Ferdinand P. Brandl, Diels-Alder hydrogels with enhanced stability: First step toward controlled release of bevacizumab European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 96, pp. 217- 225 ,(2015) , 10.1016/J.EJPB.2015.07.024
Flavio A. Rezende, Eric Lapalme, Cynthia X. Qian, Lois E. Smith, John Paul SanGiovanni, Przemyslaw Sapieha, Omega-3 Supplementation Combined With Anti–Vascular Endothelial Growth Factor Lowers Vitreal Levels of Vascular Endothelial Growth Factor in Wet Age-Related Macular Degeneration American Journal of Ophthalmology. ,vol. 158, pp. 1071- 1078 ,(2014) , 10.1016/J.AJO.2014.07.036
Jason A. Burdick, Glenn D. Prestwich, Hyaluronic Acid Hydrogels for Biomedical Applications Advanced Materials. ,vol. 23, ,(2011) , 10.1002/ADMA.201003963
Keiko Motokawa, Sei Kwang Hahn, Teruo Nakamura, Hajime Miyamoto, Tsuyoshi Shimoboji, Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin Journal of Biomedical Materials Research Part A. ,vol. 78, pp. 459- 465 ,(2006) , 10.1002/JBM.A.30759
Francesco Semeraro, Morescalchi, Sarah Duse, Francesco Parmeggiani, Gambicorti, Ciro Costagliola, Aflibercept in wet AMD: specific role and optimal use Drug Design Development and Therapy. ,vol. 7, pp. 711- 722 ,(2013) , 10.2147/DDDT.S40215
Eun Ju Oh, Kitae Park, Ki Su Kim, Jiseok Kim, Jeong-A Yang, Ji-Hyun Kong, Min Young Lee, Allan S. Hoffman, Sei Kwang Hahn, Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives Journal of Controlled Release. ,vol. 141, pp. 2- 12 ,(2010) , 10.1016/J.JCONREL.2009.09.010
Napoleone Ferrara, Hans-Peter Gerber, Jennifer LeCouter, None, The biology of VEGF and its receptors. Nature Medicine. ,vol. 9, pp. 669- 676 ,(2003) , 10.1038/NM0603-669
grupo estudio VIEW2 HHO Dominguez, None, Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. ,vol. 119, pp. 2537- 2548 ,(2012) , 10.1016/J.OPHTHA.2012.09.006